Delisting risk
NIKI · NASDAQ · Biotechnology

Niki BioSolutions (NIKI)

Develops blood-based brain-health diagnostics and provides molecular biomarker testing services.

$7.00
Pre-market+0.39 (+5.90%)
At close$6.61(−0.15%)

No news on record for this listing yet.